Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties

Huifeng Yu, Anabel Gonzalez-Gil, Yadong Wei, Steve M. Fernandes, Ryan N. Porell, Katarina Vajn, James C. Paulson, Corwin M. Nycholat, Ronald Lee Schnaar

Research output: Contribution to journalArticle

Abstract

Siglecs are transmembrane sialoglycan binding proteins, most of which are expressed on leukocyte subsets and have inhibitory motifs that translate cell surface ligation into immune suppression. In humans, Siglec-8 on eosinophils, mast cells and basophils and Siglec-9 on neutrophils, monocytes and some T-cells, mediate immune cell death, inhibition of immune mediator release and/or enhancement of anti-inflammatory mediator release. Endogenous sialoglycan ligands in tissues, mostly uncharacterized, engage siglecs on leukocytes to inhibit inflammation. Glycan array analyses demonstrated that Siglec-8, Siglec-9 and their mouse counterparts Siglec-F and Siglec-E (respectively) have distinct glycan binding specificities, with Siglec-8 more structurally restricted. Since siglecs are involved in lung inflammation, we studied Siglec-8 and Siglec-9 ligands in human lungs and airways. Siglec-8 ligands are in tracheal submucosal glands and cartilage but not airway epithelium or connective tissues, whereas Siglec-9 ligands are broadly distributed. Mouse airways do not have Siglec-8 ligands, whereas Siglec-9 ligands are on airways of both species. Extraction of human airways and lung followed by electrophoretic resolution and siglec blotting revealed Siglec-8 ligands in extracts of human trachea and cultured tracheal gland cells, but not parenchyma or cultured airway epithelial cells whereas Siglec-9 ligands were extracted from all airway and lung tissues and cells tested. Siglec-8 and Siglec-9 ligands in airways appear to be high molecular weight O-linked sialoglycoproteins. These data reveal differential glycan specificities of Siglec-8, Siglec-9 and their mouse counterparts Siglec-F and Siglec-E, and the tissue distributions and molecular characteristics of Siglec-8 and Siglec-9 sialoglycan ligands on human airways and lungs.

Original languageEnglish (US)
Pages (from-to)657-668
Number of pages12
JournalGlycobiology
Volume27
Issue number7
DOIs
StatePublished - Jul 1 2017

    Fingerprint

Keywords

  • airways
  • sialic acid
  • siglec
  • submucosal glands
  • trachea

ASJC Scopus subject areas

  • Biochemistry

Cite this

Yu, H., Gonzalez-Gil, A., Wei, Y., Fernandes, S. M., Porell, R. N., Vajn, K., Paulson, J. C., Nycholat, C. M., & Schnaar, R. L. (2017). Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties. Glycobiology, 27(7), 657-668. https://doi.org/10.1093/glycob/cwx026